Aurobindo to raise $200 mn from overseas

Aurobindo Pharma will raise $200 million through issue of Foreign Currency Convertible Bonds (FCCBs) in overseas markets.

In order to fund its overseas acquisitions and future growth requirements Aurobindo Pharma will raise $200 million through issue of Foreign Currency Convertible Bonds (FCCBs) in overseas markets.

HT Image

The board of directors at their meeting held on April one, has approved the raising of funds from the international markets, the company informed the Bombay Stock Exchange.

The company has decided to convene an Extra Ordinary General Meeting (EGM) of the shareholders on April 27 to seek their approval, it said.